5 Stocks Targeted By Short Sellers Recently

Page 5 of 5

1. Ensysce Biosciences, Inc. (NASDAQ:ENSC)

Change In Short Interest Percentage: 31.66

Ensysce Biosciences, Inc. (NASDAQ:ENSC) is an American biotechnology firm that develops treatments for opioid abuse and addiction. Its short interest is 48,390 shares up from February’s 22,930.

Two of the 943 hedge funds surveyed by Insider Monkey for their Q4 2022 investments had held a stake in the firm.

Follow Ensysce Biosciences Inc.

Disclosure: None. You can also take a look at 14 Cheap Quarterly Dividend Stocks to Buy and 13 Best Medical Stocks To Invest In.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5